HealthCuring Blindness Through Gene Therapy Might Soon Be Allowed By The FDA Patients whose blindness is a result of an RPE65 gene might soon consider Luxturna, a form of gene therapy that improves vision. Its approval will soon be deliberated by the U.S. Food and Drug Administration.by Carl Velasco
HealthNew Technique Using Artificially Produced Sperm Could Overcome Genetic Male Infertility: Studyby Athena Chan
HealthScientists Successfully Use CRISPR-Edited Skin Grafts To Treat Type-2 Diabetes And Obesityby Luan Chan